THERAPY OF ENDOCRINE DISEASE: Denosumab versus bisphosphonates for the treatment of postmenopausal osteoporosis.

In conclusion, both bisphosphonates and denosumab are safe and efficient therapeutic options although their particularities should be carefully considered in an individual base. PMID: 29691303 [PubMed - as supplied by publisher]
Source: European Journal of Endocrinology - Category: Endocrinology Authors: Tags: Eur J Endocrinol Source Type: research